Erina Vlashi

Title(s)Associate Adjunct Professor, Radiation Oncology
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Purdue University, IndianaPhD2007Chemistry
    UCLA, Los AngelesPost-doc2010Cancer stem cell radiobiology

    Collapse Overview 

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. M2 isoform of pyruvate kinase rewires glucose metabolism during radiation therapy to promote an antioxidant response and glioblastoma radioresistance. Neuro Oncol. 2023 11 02; 25(11):1989-2000. Bailleul J, Ruan Y, Abdulrahman L, Scott AJ, Yazal T, Sung D, Park K, Hoang H, Nathaniel J, Chu FI, Palomera D, Sehgal A, Tsang JE, Nathanson DA, Xu S, Park JO, Ten Hoeve J, Bhat K, Qi N, Kornblum HI, Schaue D, McBride WH, Lyssiotis CA, Wahl DR, Vlashi E. PMID: 37279645; PMCID: PMC10628945.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    2. Nicotinamide Adenine Dinucleotide Phosphate Oxidase Promotes Glioblastoma Radiation Resistance in a Phosphate and Tensin Homolog-Dependent Manner. Antioxid Redox Signal. 2023 11; 39(13-15):890-903. Ludwig K, Le Belle JE, Muthukrishnan SD, Sperry J, Condro M, Vlashi E, Pajonk F, Kornblum HI. PMID: 37470216; PMCID: PMC10775910.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Glioblastomas: Hijacking Metabolism to Build a Flexible Shield for Therapy Resistance. Antioxid Redox Signal. 2023 11; 39(13-15):957-979. Bailleul J, Vlashi E. PMID: 37022791; PMCID: PMC10655009.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. NRF2 Mediates Cellular Resistance to Transformation, Radiation, and Inflammation in Mice. Antioxidants (Basel). 2022 Aug 25; 11(9). Schaue D, Micewicz ED, Ratikan JA, Iwamoto KS, Vlashi E, McDonald JT, McBride WH. PMID: 36139722; PMCID: PMC9495793.
      View in: PubMed   Mentions: 1  
    5. Metabolic response to radiation therapy in cancer. Mol Carcinog. 2022 02; 61(2):200-224. Read GH, Bailleul J, Vlashi E, Kesarwala AH. PMID: 34961986; PMCID: PMC10187995.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    6. Radiosensitizing Pancreatic Cancer via Effective Autophagy Inhibition. Mol Cancer Ther. 2022 01; 21(1):79-88. Yazal T, Bailleul J, Ruan Y, Sung D, Chu FI, Palomera D, Dao A, Sehgal A, Gurunathan V, Aryan L, Eghbali M, Vlashi E. PMID: 34725193.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    7. Three discipline collaborative radiation therapy (3DCRT) special debate: Peer review in radiation oncology is more effective today than 20 years ago. J Appl Clin Med Phys. 2020 Nov; 21(11):7-13. Ahmad A, Santanam L, Solanki AA, Padilla L, Vlashi E, Guerrieri P, Dominello MM, Burmeister J, Joiner MC. PMID: 33232567; PMCID: PMC7700926.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma. Proc Natl Acad Sci U S A. 2020 05 19; 117(20):11085-11096. Bhat K, Saki M, Vlashi E, Cheng F, Duhachek-Muggy S, Alli C, Yu G, Medina P, He L, Damoiseaux R, Pellegrini M, Zemke NR, Nghiemphu PL, Cloughesy TF, Liau LM, Kornblum HI, Pajonk F. PMID: 32358191; PMCID: PMC7245100.
      View in: PubMed   Mentions: 17     Fields:    Translation:Animals
    9. Radiation mitigation of the intestinal acute radiation injury in mice by 1-[(4-nitrophenyl)sulfonyl]-4-phenylpiperazine. Stem Cells Transl Med. 2020 01; 9(1):106-119. Duhachek-Muggy S, Bhat K, Medina P, Cheng F, He L, Alli C, Saki M, Muthukrishnan SD, Ruffenach G, Eghbali M, Vlashi E, Pajonk F. PMID: 31464098; PMCID: PMC6954722.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsPHPublic Health
    10. PK-M2-mediated metabolic changes in breast cancer cells induced by ionizing radiation. Breast Cancer Res Treat. 2019 Nov; 178(1):75-86. Zhang L, Bailleul J, Yazal T, Dong K, Sung D, Dao A, Gosa L, Nathanson D, Bhat K, Duhachek-Muggy S, Alli C, Dratver MB, Pajonk F, Vlashi E. PMID: 31372790; PMCID: PMC6790295.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    11. The KRAS-variant and its impact on normal breast epithelial cell biology. Cell Death Differ. 2019 12; 26(12):2568-2576. Jung SY, Malhotra P, Nguyen KC, Salzman D, Qi Y, Pak EH, King J, Vlashi E, Ann D, Weidhaas JB. PMID: 30932013; PMCID: PMC7224195.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    12. Three discipline collaborative radiation therapy (3DCRT) special debate: I would treat all early-stage NSCLC patients with SBRT. J Appl Clin Med Phys. 2019 03; 20(3):7-13. Mohindra P, Sawant A, Griffin RJ, Lamichhane N, Vlashi E, Xu-Welliver M, Dominello M, Joiner MC, Burmeister J. PMID: 30793828; PMCID: PMC6414141.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. If It Seems Too Good to Be True…. Int J Radiat Oncol Biol Phys. 2019 02 01; 103(2):305-307. Steinberg ML, McBride WH, Vlashi E, Pajonk F. PMID: 30647007.
      View in: PubMed   Mentions:    Fields:    
    14. Serum erythropoietin levels, breast cancer and breast cancer-initiating cells. Breast Cancer Res. 2019 01 30; 21(1):17. Bhat K, Sandler K, Duhachek-Muggy S, Alli C, Cheng F, Moatamed NA, Magyar CE, Du L, Li G, McCloskey S, Vlashi E, Pajonk F. PMID: 30700319; PMCID: PMC6354373.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    15. 1-(4-nitrobenzenesulfonyl)-4-penylpiperazine increases the number of Peyer's patch-associated regenerating crypts in the small intestines after radiation injury. Radiother Oncol. 2019 03; 132:8-15. Bhat K, Duhachek-Muggy S, Ramanathan R, Saki M, Alli C, Medina P, Damoiseaux R, Whitelegge J, McBride WH, Schaue D, Vlashi E, Pajonk F. PMID: 30825974; PMCID: PMC6400303.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsPHPublic Health
    16. Mebendazole Potentiates Radiation Therapy in Triple-Negative Breast Cancer. Int J Radiat Oncol Biol Phys. 2019 01 01; 103(1):195-207. Zhang L, Bochkur Dratver M, Yazal T, Dong K, Nguyen A, Yu G, Dao A, Bochkur Dratver M, Duhachek-Muggy S, Bhat K, Alli C, Pajonk F, Vlashi E. PMID: 30196056; PMCID: PMC6457649.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    17. Growth Differentiation Factor 11 does not Mitigate the Lethal Effects of Total-Abdominal Irradiation. Radiat Res. 2017 11; 188(5):469-475. Duhachek-Muggy S, Bhat K, Vlashi E, Pajonk F. PMID: 28829672; PMCID: PMC5709091.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    18. Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer. Cell Cycle. 2017 Apr 18; 16(8):737-745. Zhang L, Xu L, Zhang F, Vlashi E. PMID: 27753527; PMCID: PMC5405729.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    19. Radiation-Induced Dedifferentiation of Head and Neck Cancer Cells Into Cancer Stem Cells Depends on Human Papillomavirus Status. Int J Radiat Oncol Biol Phys. 2016 Apr 01; 94(5):1198-206. Vlashi E, Chen AM, Boyrie S, Yu G, Nguyen A, Brower PA, Hess CB, Pajonk F. PMID: 27026319; PMCID: PMC4817367.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansAnimalsCells
    20. The metabolic state of cancer stem cells-a valid target for cancer therapy? Free Radic Biol Med. 2015 Feb; 79:264-8. Vlashi E, Pajonk F. PMID: 25450330; PMCID: PMC4339632.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    21. Folate receptor-β in activated macrophages: ligand binding and receptor recycling kinetics. Mol Pharm. 2014 Oct 06; 11(10):3609-16. Varghese B, Vlashi E, Xia W, Ayala Lopez W, Paulos CM, Reddy J, Xu LC, Low PS. PMID: 25166491.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    22. Cancer stem cells, cancer cell plasticity and radiation therapy. Semin Cancer Biol. 2015 Apr; 31:28-35. Vlashi E, Pajonk F. PMID: 25025713; PMCID: PMC4291301.
      View in: PubMed   Mentions: 132     Fields:    Translation:HumansCells
    23. Metabolic differences in breast cancer stem cells and differentiated progeny. Breast Cancer Res Treat. 2014 Aug; 146(3):525-34. Vlashi E, Lagadec C, Vergnes L, Reue K, Frohnen P, Chan M, Alhiyari Y, Dratver MB, Pajonk F. PMID: 25007966; PMCID: PMC4131557.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCells
    24. Tumor cells with low proteasome subunit expression predict overall survival in head and neck cancer patients. BMC Cancer. 2014 Mar 05; 14:152. Lagadec C, Vlashi E, Bhuta S, Lai C, Mischel P, Werner M, Henke M, Pajonk F. PMID: 24593279; PMCID: PMC3975871.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    25. The RNA-binding protein Musashi-1 regulates proteasome subunit expression in breast cancer- and glioma-initiating cells. Stem Cells. 2014 Jan; 32(1):135-44. Lagadec C, Vlashi E, Frohnen P, Alhiyari Y, Chan M, Pajonk F. PMID: 24022895; PMCID: PMC3968686.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    26. Characterization of the stem cell niche and its importance in radiobiological response. Semin Radiat Oncol. 2013 Oct; 23(4):237-41. Pajonk F, Vlashi E. PMID: 24012337; PMCID: PMC3768002.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    27. Effect of folate-targeted nanoparticle size on their rates of penetration into solid tumors. ACS Nano. 2013 Oct 22; 7(10):8573-82. Vlashi E, Kelderhouse LE, Sturgis JE, Low PS. PMID: 24020507.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    28. Targeted elimination of breast cancer cells with low proteasome activity is sufficient for tumor regression. Breast Cancer Res Treat. 2013 Sep; 141(2):197-203. Vlashi E, Lagadec C, Chan M, Frohnen P, McDonald AJ, Pajonk F. PMID: 24013708; PMCID: PMC3814133.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    29. Radiation-induced Notch signaling in breast cancer stem cells. Int J Radiat Oncol Biol Phys. 2013 Nov 01; 87(3):609-18. Lagadec C, Vlashi E, Alhiyari Y, Phillips TM, Bochkur Dratver M, Pajonk F. PMID: 23992604; PMCID: PMC3788036.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsCells
    30. National Institutes of Health funding in radiation oncology: a snapshot. Int J Radiat Oncol Biol Phys. 2013 Jun 01; 86(2):234-40. Steinberg M, McBride WH, Vlashi E, Pajonk F. PMID: 23523324; PMCID: PMC3646925.
      View in: PubMed   Mentions: 15     Fields:    
    31. Radiation-induced reprogramming of breast cancer cells. Stem Cells. 2012 May; 30(5):833-44. Lagadec C, Vlashi E, Della Donna L, Dekmezian C, Pajonk F. PMID: 22489015; PMCID: PMC3413333.
      View in: PubMed   Mentions: 191     Fields:    Translation:HumansCells
    32. Folate-linked drugs for the treatment of cancer and inflammatory diseases. Subcell Biochem. 2012; 56:163-79. Yang J, Vlashi E, Low P. PMID: 22116699.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimals
    33. Metabolic state of glioma stem cells and nontumorigenic cells. Proc Natl Acad Sci U S A. 2011 Sep 20; 108(38):16062-7. Vlashi E, Lagadec C, Vergnes L, Matsutani T, Masui K, Poulou M, Popescu R, Della Donna L, Evers P, Dekmezian C, Reue K, Christofk H, Mischel PS, Pajonk F. PMID: 21900605; PMCID: PMC3179043.
      View in: PubMed   Mentions: 284     Fields:    Translation:HumansCells
    34. Ionizing radiation activates the Nrf2 antioxidant response. Cancer Res. 2010 Nov 01; 70(21):8886-95. McDonald JT, Kim K, Norris AJ, Vlashi E, Phillips TM, Lagadec C, Della Donna L, Ratikan J, Szelag H, Hlatky L, McBride WH. PMID: 20940400; PMCID: PMC2970706.
      View in: PubMed   Mentions: 100     Fields:    Translation:AnimalsCells
    35. Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisited. Stem Cells. 2010 Apr; 28(4):639-48. Pajonk F, Vlashi E, McBride WH. PMID: 20135685; PMCID: PMC2940232.
      View in: PubMed   Mentions: 158     Fields:    Translation:HumansAnimalsCells
    36. Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment. Breast Cancer Res. 2010; 12(1):R13. Lagadec C, Vlashi E, Della Donna L, Meng Y, Dekmezian C, Kim K, Pajonk F. PMID: 20158881; PMCID: PMC2880434.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansCells
    37. Targeted cancer stem cell therapies start with proper identification of the target. Mol Cancer Res. 2010 Feb; 8(2):291; author reply 291. Vlashi E, Pajonk F. PMID: 20145040; PMCID: PMC2824786.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    38. Differential Effects of the Proteasome Inhibitor NPI-0052 against Glioma Cells. Transl Oncol. 2010 Feb; 3(1):50-5. Vlashi E, Mattes M, Lagadec C, Donna LD, Phillips TM, Nikolay P, McBride WH, Pajonk F. PMID: 20165695; PMCID: PMC2822455.
      View in: PubMed   Mentions: 15  
    39. Real time, noninvasive imaging and quantitation of the accumulation of ligand-targeted drugs into receptor-expressing solid tumors. Mol Pharm. 2009 Nov-Dec; 6(6):1868-75. Vlashi E, Sturgis JE, Thomas M, Low PS. PMID: 19754150.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    40. Radiation responses of cancer stem cells. J Cell Biochem. 2009 Oct 01; 108(2):339-42. Vlashi E, McBride WH, Pajonk F. PMID: 19623582; PMCID: PMC2865474.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansAnimalsCells
    41. In vivo imaging, tracking, and targeting of cancer stem cells. J Natl Cancer Inst. 2009 Mar 04; 101(5):350-9. Vlashi E, Kim K, Lagadec C, Donna LD, McDonald JT, Eghbali M, Sayre JW, Stefani E, McBride W, Pajonk F. PMID: 19244169; PMCID: PMC2727141.
      View in: PubMed   Mentions: 126     Fields:    Translation:HumansAnimalsCells
    42. Effects of recombinant erythropoietin on breast cancer-initiating cells. Neoplasia. 2007 Dec; 9(12):1122-9. Phillips TM, Kim K, Vlashi E, McBride WH, Pajonk F. PMID: 18084619; PMCID: PMC2134908.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    43. Immunomagnetic diffractometry for detection of diagnostic serum markers. J Am Chem Soc. 2007 Dec 26; 129(51):15824-9. Acharya G, Chang CL, Doorneweerd DD, Vlashi E, Henne WA, Hartmann LC, Low PS, Savran CA. PMID: 18047330.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    44. Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis. Arthritis Res Ther. 2006; 8(3):R77. Paulos CM, Varghese B, Widmer WR, Breur GJ, Vlashi E, Low PS. PMID: 16646988; PMCID: PMC1526647.
      View in: PubMed   Mentions: 27     Fields:    Translation:AnimalsCells
    Erina's Networks
    Concepts (249)
    Derived automatically from this person's publications.
    Co-Authors (19)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department